5 Am Ventures V, L.P. is of Entrada Therapeutics, Inc.. Currently has a direct ownership of 3.16 Million shares of TRDA, which is worth approximately $20.2 Million. The most recent transaction as insider was on Jul 09, 2025, when has been sold 20,065 shares (Common Stock) at a price of $7.5 per share, resulting in proceeds of $150,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.16M
n/a 3M change
n/a 12M change
Total Value Held $20.2 Million

5AM Ventures V, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 09 2025
SELL
Open market or private sale
$150,487 $7.5 p/Share
20,065 Reduced 0.63%
3,163,066 Common Stock
Jul 01 2025
SELL
Open market or private sale
$132,275 $7.12 p/Share
18,578 Reduced 0.58%
3,183,131 Common Stock
Jun 30 2025
SELL
Open market or private sale
$126,516 $6.81 p/Share
18,578 Reduced 0.58%
3,201,709 Common Stock
Jun 27 2025
SELL
Open market or private sale
$385,128 $6.91 p/Share
55,735 Reduced 1.7%
3,220,287 Common Stock

Also insider at

CABA
Cabaletta Bio, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
IMPL
IMPEL PHARMACEUTICALS INC Healthcare
5VV

5 Am Ventures V, L.P.

San Francisco, CA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA